QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sellas-life-sciences-announced-review-of-ongoing-phase-3-regal-clinical-trial-of-galinpepimut-s-in-acute-myeloid-leukemia-by-idmc

–  The Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Without Any Modifications ––...

 sellas-life-sciences-completes-enrollment-and-reports-positive-initial-data-from-phase-2a-trial-of-sls009-in-relapsedrefractory-acute-myeloid-leukemia

- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - Overall Response Rate (ORR) of 3...

 sellas-life-sciences-gr-q1-2024-adj-eps-021-misses-016-estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate...

 sellas-life-sciences-announces-recommendation-of-independent-data-monitoring-committee-following-completion-of-enrollment-in-regal-phase-3-study

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of P...

 sellas-life-sciences-gr-q4-eps-025-misses-021-estimate

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate...

 sellas-announces-topline-data-from-phase-2a-study-of-sls009-in-relapsedrefractory-acute-myeloid-leukemia-and-provides-steering-committee-update-on-phase-3-regal-study

Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Schedu...

 dow-falls-over-200-points-adobe-shares-plunge

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded...

 why-jabil-shares-are-trading-lower-by-over-14-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter resu...

 crude-oil-edges-lower-us-consumer-sentiment-falls-in-march

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded do...

 nasdaq-down-over-100-points-hibbett-reports-downbeat-sales

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Friday. Following the market ...

 sellas-life-sciences-delivers-oral-presentation-of-sls009-phase-1-data-for-acute-myeloid-leukemia-patients-at-2024-european-school-of-haematology-conference

- All key study objectives regarding pharmacokinetic, pharmacodynamic, safety, and clinical activity were met -- Complete remis...